The identification and characterization of the hepcidin molecule could help to better define the condition of sideropenia and monitor the response to treatment in the presence of certain etiopathogenetic moments, such as concomitant infection, anemia related to inflammation, and genetic iron deficiency anemia refractory to oral treatment (IRIDA). This evidence concerns the gene HAMP and anemia.